Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 66 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬African trypanosomiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬1. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 66 diseases |
IL1B [1] IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬African trypanosomiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬2. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬AGE-RAGE signaling pathway in diabetic complications
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬3. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
IL1B [1] IL1B 💬AGE-RAGE signaling pathway in diabetic complications
|
Canakinumab Canakinumab 💬AGE-RAGE signaling pathway in diabetic complications
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬4. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
IL1B [1] IL1B 💬Alcoholic liver disease
|
Canakinumab Canakinumab 💬Alcoholic liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬5. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
IL1B [1] IL1B 💬Alcoholic liver disease
|
Rilonacept Rilonacept 💬Alcoholic liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬6. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Alzheimer disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬7. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
IL1B [1] IL1B 💬Alzheimer disease
|
Canakinumab Canakinumab 💬Alzheimer disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬8. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Alzheimer disease
|
Colchicine Colchicine 💬Alzheimer disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬9. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
IL1B [1] IL1B 💬Amoebiasis
|
Canakinumab Canakinumab 💬Amoebiasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬10. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
IL1B [1] IL1B 💬Amoebiasis
|
Rilonacept Rilonacept 💬Amoebiasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬11. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
IL1R1 [2] IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Amoebiasis
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬12. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Amyotrophic lateral sclerosis
|
Colchicine Colchicine 💬Amyotrophic lateral sclerosis
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬13. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
IL1B [1] IL1B 💬C-type lectin receptor signaling pathway
|
Canakinumab Canakinumab 💬C-type lectin receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬14. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
IL1B [1] IL1B 💬C-type lectin receptor signaling pathway
|
Rilonacept Rilonacept 💬C-type lectin receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬15. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
IL1A [1] IL1A 💬Cellular senescence
|
Rilonacept Rilonacept 💬Cellular senescence
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬16. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
IL1B [1] IL1B 💬Chagas disease
|
Canakinumab Canakinumab 💬Chagas disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬17. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
IL1B [1] IL1B 💬Chagas disease
|
Rilonacept Rilonacept 💬Chagas disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬18. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
IL1B [1] IL1B 💬Coronavirus disease
|
Canakinumab Canakinumab 💬Coronavirus disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬19. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
IL1B [1] IL1B 💬Coronavirus disease
|
Rilonacept Rilonacept 💬Coronavirus disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬20. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
IL6R [1] IL6R 💬Coronavirus disease
|
Tocilizumab Tocilizumab 💬Coronavirus disease
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬21. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Cytokine-cytokine receptor interaction
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬22. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL1B [1] IL1B 💬Cytokine-cytokine receptor interaction
|
Canakinumab Canakinumab 💬Cytokine-cytokine receptor interaction
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬23. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL1R1 [2] IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Cytokine-cytokine receptor interaction
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬24. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL6R [1] IL6R 💬Cytokine-cytokine receptor interaction
|
Tocilizumab Tocilizumab 💬Cytokine-cytokine receptor interaction
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬25. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Cytosolic DNA-sensing pathway 💬 21 genes, 17 drugs (DrugBank) and 34 diseases |
IL1B [1] IL1B 💬Cytosolic DNA-sensing pathway
|
Canakinumab Canakinumab 💬Cytosolic DNA-sensing pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬26. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Cytosolic DNA-sensing pathway 💬 21 genes, 17 drugs (DrugBank) and 34 diseases |
IL1B [1] IL1B 💬Cytosolic DNA-sensing pathway
|
Rilonacept Rilonacept 💬Cytosolic DNA-sensing pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬27. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Fluid shear stress and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬28. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
IL1B [1] IL1B 💬Fluid shear stress and atherosclerosis
|
Canakinumab Canakinumab 💬Fluid shear stress and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬29. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
IL1R1 [2] IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Fluid shear stress and atherosclerosis
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬30. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Gap junction
|
Colchicine Colchicine 💬Gap junction
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬31. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Graft-versus-host disease 💬 28 genes, 26 drugs (DrugBank) and 68 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Graft-versus-host disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬32. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Graft-versus-host disease 💬 28 genes, 26 drugs (DrugBank) and 68 diseases |
IL1B [1] IL1B 💬Graft-versus-host disease
|
Canakinumab Canakinumab 💬Graft-versus-host disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬33. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Hematopoietic cell lineage
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬34. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL1B [1] IL1B 💬Hematopoietic cell lineage
|
Canakinumab Canakinumab 💬Hematopoietic cell lineage
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬35. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL1R1 [2] IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Hematopoietic cell lineage
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬36. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL6R [1] IL6R 💬Hematopoietic cell lineage
|
Tocilizumab Tocilizumab 💬Hematopoietic cell lineage
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬37. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
IL1B [1] IL1B 💬Herpes simplex virus 1 infection
|
Canakinumab Canakinumab 💬Herpes simplex virus 1 infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬38. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
IL1B [1] IL1B 💬Herpes simplex virus 1 infection
|
Rilonacept Rilonacept 💬Herpes simplex virus 1 infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬39. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
IL6R [1] IL6R 💬HIF-1 signaling pathway
|
Tocilizumab Tocilizumab 💬HIF-1 signaling pathway
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬40. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
IL1B [1] IL1B 💬Human cytomegalovirus infection
|
Canakinumab Canakinumab 💬Human cytomegalovirus infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬41. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
IL1B [1] IL1B 💬Human cytomegalovirus infection
|
Rilonacept Rilonacept 💬Human cytomegalovirus infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬42. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
IL1R1 [1] IL1R1 💬Human cytomegalovirus infection
|
Anakinra Anakinra 💬Human cytomegalovirus infection
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬43. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
IL6R [1] IL6R 💬Human cytomegalovirus infection
|
Tocilizumab Tocilizumab 💬Human cytomegalovirus infection
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬44. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
IL1R1 [2] IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Human T-cell leukemia virus 1 infection
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬45. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Huntington disease
|
Colchicine Colchicine 💬Huntington disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬46. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬IgSF CAM signaling
|
Colchicine Colchicine 💬IgSF CAM signaling
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬47. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
IL1B [1] IL1B 💬IL-17 signaling pathway
|
Canakinumab Canakinumab 💬IL-17 signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬48. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
IL1B [1] IL1B 💬IL-17 signaling pathway
|
Rilonacept Rilonacept 💬IL-17 signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬49. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Inflammatory bowel disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬50. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL1B [1] IL1B 💬Inflammatory bowel disease
|
Canakinumab Canakinumab 💬Inflammatory bowel disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬51. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
IL1B [1] IL1B 💬Inflammatory mediator regulation of TRP channels
|
Canakinumab Canakinumab 💬Inflammatory mediator regulation of TRP channels
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬52. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
IL1B [1] IL1B 💬Inflammatory mediator regulation of TRP channels
|
Rilonacept Rilonacept 💬Inflammatory mediator regulation of TRP channels
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬53. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
IL1R1 [1] IL1R1 💬Inflammatory mediator regulation of TRP channels
|
Anakinra Anakinra 💬Inflammatory mediator regulation of TRP channels
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬54. Inflammatory mediator regulation of TRP channels
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Influenza A
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬55. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
IL1B [1] IL1B 💬Influenza A
|
Canakinumab Canakinumab 💬Influenza A
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬56. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
IL6R [1] IL6R 💬JAK-STAT signaling pathway
|
Tocilizumab Tocilizumab 💬JAK-STAT signaling pathway
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬57. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Legionellosis 💬 10 genes, 24 drugs (DrugBank) and 68 diseases |
IL1B [1] IL1B 💬Legionellosis
|
Canakinumab Canakinumab 💬Legionellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬58. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Legionellosis 💬 10 genes, 24 drugs (DrugBank) and 68 diseases |
IL1B [1] IL1B 💬Legionellosis
|
Rilonacept Rilonacept 💬Legionellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬59. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Leishmaniasis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬60. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
IL1B [1] IL1B 💬Leishmaniasis
|
Canakinumab Canakinumab 💬Leishmaniasis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬61. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
IL1B [1] IL1B 💬Lipid and atherosclerosis
|
Canakinumab Canakinumab 💬Lipid and atherosclerosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬62. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
IL1B [1] IL1B 💬Lipid and atherosclerosis
|
Rilonacept Rilonacept 💬Lipid and atherosclerosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬63. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Malaria 💬 17 genes, 31 drugs (DrugBank) and 69 diseases |
IL1B [1] IL1B 💬Malaria
|
Canakinumab Canakinumab 💬Malaria
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬64. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Malaria 💬 17 genes, 31 drugs (DrugBank) and 69 diseases |
IL1B [1] IL1B 💬Malaria
|
Rilonacept Rilonacept 💬Malaria
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬65. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬MAPK signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬66. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
IL1B [1] IL1B 💬MAPK signaling pathway
|
Canakinumab Canakinumab 💬MAPK signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬67. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
IL1R1 [1] IL1R1 💬MAPK signaling pathway
|
Anakinra Anakinra 💬MAPK signaling pathway
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬68. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Measles
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬69. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
IL1B [1] IL1B 💬Measles
|
Canakinumab Canakinumab 💬Measles
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬70. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Motor proteins 💬 25 genes, 10 drugs (DrugBank) and 21 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Motor proteins
|
Colchicine Colchicine 💬Motor proteins
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬71. Motor proteins
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Necroptosis 💬 34 genes, 60 drugs (DrugBank) and 82 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Necroptosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬72. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Necroptosis 💬 34 genes, 60 drugs (DrugBank) and 82 diseases |
IL1B [1] IL1B 💬Necroptosis
|
Canakinumab Canakinumab 💬Necroptosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬73. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
IL1B [1] IL1B 💬NF-kappa B signaling pathway
|
Canakinumab Canakinumab 💬NF-kappa B signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬74. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
IL1B [1] IL1B 💬NF-kappa B signaling pathway
|
Rilonacept Rilonacept 💬NF-kappa B signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬75. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
IL1R1 [1] IL1R1 💬NF-kappa B signaling pathway
|
Anakinra Anakinra 💬NF-kappa B signaling pathway
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬76. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | NOD-like receptor signaling pathway 💬 33 genes, 57 drugs (DrugBank) and 79 diseases |
IL1B [1] IL1B 💬NOD-like receptor signaling pathway
|
Canakinumab Canakinumab 💬NOD-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬77. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | NOD-like receptor signaling pathway 💬 33 genes, 57 drugs (DrugBank) and 79 diseases |
IL1B [1] IL1B 💬NOD-like receptor signaling pathway
|
Rilonacept Rilonacept 💬NOD-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬78. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Non-alcoholic fatty liver disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬79. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
IL1B [1] IL1B 💬Non-alcoholic fatty liver disease
|
Canakinumab Canakinumab 💬Non-alcoholic fatty liver disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬80. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
IL6R [1] IL6R 💬Non-alcoholic fatty liver disease
|
Tocilizumab Tocilizumab 💬Non-alcoholic fatty liver disease
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬81. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Osteoclast differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬82. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
IL1B [1] IL1B 💬Osteoclast differentiation
|
Canakinumab Canakinumab 💬Osteoclast differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬83. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
IL1R1 [1] IL1R1 💬Osteoclast differentiation
|
Anakinra Anakinra 💬Osteoclast differentiation
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬84. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Parkinson disease
|
Colchicine Colchicine 💬Parkinson disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬85. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
IL1B [1] IL1B 💬Pathogenic Escherichia coli infection
|
Canakinumab Canakinumab 💬Pathogenic Escherichia coli infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬86. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
IL1B [1] IL1B 💬Pathogenic Escherichia coli infection
|
Rilonacept Rilonacept 💬Pathogenic Escherichia coli infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬87. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
IL1R1 [1] IL1R1 💬Pathogenic Escherichia coli infection
|
Anakinra Anakinra 💬Pathogenic Escherichia coli infection
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬88. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathogenic Escherichia coli infection
|
Colchicine Colchicine 💬Pathogenic Escherichia coli infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬89. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IL6R [1] IL6R 💬Pathways in cancer
|
Tocilizumab Tocilizumab 💬Pathways in cancer
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬90. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Pathways of neurodegeneration - multiple diseases
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬91. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
IL1B [1] IL1B 💬Pathways of neurodegeneration - multiple diseases
|
Canakinumab Canakinumab 💬Pathways of neurodegeneration - multiple diseases
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬92. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathways of neurodegeneration - multiple diseases
|
Colchicine Colchicine 💬Pathways of neurodegeneration - multiple diseases
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬93. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Pertussis 💬 23 genes, 48 drugs (DrugBank) and 77 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Pertussis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬94. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Pertussis 💬 23 genes, 48 drugs (DrugBank) and 77 diseases |
IL1B [1] IL1B 💬Pertussis
|
Canakinumab Canakinumab 💬Pertussis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬95. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Phagocytosis
|
Colchicine Colchicine 💬Phagocytosis
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬96. Phagocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
IL6R [1] IL6R 💬PI3K-Akt signaling pathway
|
Tocilizumab Tocilizumab 💬PI3K-Akt signaling pathway
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬97. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Prion disease
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬98. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
IL1B [1] IL1B 💬Prion disease
|
Canakinumab Canakinumab 💬Prion disease
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬99. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Prion disease
|
Colchicine Colchicine 💬Prion disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬100. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
IL1R2 [1] IL1R2 💬Prostate cancer
|
Anakinra Anakinra 💬Prostate cancer
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬101. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Rheumatoid arthritis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬102. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
IL1B [1] IL1B 💬Rheumatoid arthritis
|
Canakinumab Canakinumab 💬Rheumatoid arthritis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬103. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
IL1B [1] IL1B 💬Salmonella infection
|
Canakinumab Canakinumab 💬Salmonella infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬104. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
IL1B [1] IL1B 💬Salmonella infection
|
Rilonacept Rilonacept 💬Salmonella infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬105. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Salmonella infection
|
Colchicine Colchicine 💬Salmonella infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬106. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
IL1B [1] IL1B 💬Shigellosis
|
Canakinumab Canakinumab 💬Shigellosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬107. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
IL1B [1] IL1B 💬Shigellosis
|
Rilonacept Rilonacept 💬Shigellosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬108. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
IL1R1 [1] IL1R1 💬Shigellosis
|
Anakinra Anakinra 💬Shigellosis
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬109. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL1B [1] IL1B 💬Th17 cell differentiation
|
Canakinumab Canakinumab 💬Th17 cell differentiation
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬110. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL1B [1] IL1B 💬Th17 cell differentiation
|
Rilonacept Rilonacept 💬Th17 cell differentiation
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬111. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL1R1 [1] IL1R1 💬Th17 cell differentiation
|
Anakinra Anakinra 💬Th17 cell differentiation
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬112. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL6R [1] IL6R 💬Th17 cell differentiation
|
Tocilizumab Tocilizumab 💬Th17 cell differentiation
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬113. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
IL1B [1] IL1B 💬TNF signaling pathway
|
Canakinumab Canakinumab 💬TNF signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬114. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
IL1B [1] IL1B 💬TNF signaling pathway
|
Rilonacept Rilonacept 💬TNF signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬115. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
IL1B [1] IL1B 💬Toll-like receptor signaling pathway
|
Canakinumab Canakinumab 💬Toll-like receptor signaling pathway
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬116. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
IL1B [1] IL1B 💬Toll-like receptor signaling pathway
|
Rilonacept Rilonacept 💬Toll-like receptor signaling pathway
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬117. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
IL1R2 [1] IL1R2 💬Transcriptional misregulation in cancer
|
Anakinra Anakinra 💬Transcriptional misregulation in cancer
| Anakinra | 002 [22] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬118. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Tuberculosis
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬119. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
IL1B [1] IL1B 💬Tuberculosis
|
Canakinumab Canakinumab 💬Tuberculosis
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬120. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 72 diseases |
IL1A [2] IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Type I diabetes mellitus
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬121. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 72 diseases |
IL1B [1] IL1B 💬Type I diabetes mellitus
|
Canakinumab Canakinumab 💬Type I diabetes mellitus
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬122. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Viral protein interaction with cytokine and cytokine receptor 💬 18 genes, 31 drugs (DrugBank) and 68 diseases |
IL6R [1] IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Tocilizumab Tocilizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Tocilizumab | 002 [26] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬123. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
IL1B [1] IL1B 💬Yersinia infection
|
Canakinumab Canakinumab 💬Yersinia infection
| Canakinumab | 046 [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬124. Yersinia infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
IL1B [1] IL1B 💬Yersinia infection
|
Rilonacept Rilonacept 💬Yersinia infection
| Rilonacept | 051 [5] 51, 84, 106, 107, 266 💬125. Yersinia infection
|
African trypanosomiasis
10 genes, 24 drugs (DrugBank) and 66 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Alcoholic liver disease
43 genes, 56 drugs (DrugBank) and 98 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 77 diseases
Amyotrophic lateral sclerosis
39 genes, 58 drugs (DrugBank) and 116 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cytokine-cytokine receptor interaction
90 genes, 141 drugs (DrugBank) and 104 diseases
Cytosolic DNA-sensing pathway
21 genes, 17 drugs (DrugBank) and 34 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Graft-versus-host disease
28 genes, 26 drugs (DrugBank) and 68 diseases
Hematopoietic cell lineage
47 genes, 97 drugs (DrugBank) and 101 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
Huntington disease
26 genes, 42 drugs (DrugBank) and 91 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Inflammatory bowel disease
38 genes, 49 drugs (DrugBank) and 75 diseases
Inflammatory mediator regulation of TRP channels
26 genes, 55 drugs (DrugBank) and 70 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Legionellosis
10 genes, 24 drugs (DrugBank) and 68 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Malaria
17 genes, 31 drugs (DrugBank) and 69 diseases
MAPK signaling pathway
70 genes, 101 drugs (DrugBank) and 117 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Motor proteins
25 genes, 10 drugs (DrugBank) and 21 diseases
Necroptosis
34 genes, 60 drugs (DrugBank) and 82 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
NOD-like receptor signaling pathway
33 genes, 57 drugs (DrugBank) and 79 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Parkinson disease
24 genes, 73 drugs (DrugBank) and 71 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Pertussis
23 genes, 48 drugs (DrugBank) and 77 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Rheumatoid arthritis
39 genes, 59 drugs (DrugBank) and 85 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Shigellosis
31 genes, 54 drugs (DrugBank) and 97 diseases
Th17 cell differentiation
57 genes, 88 drugs (DrugBank) and 111 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Transcriptional misregulation in cancer
28 genes, 64 drugs (DrugBank) and 83 diseases
Tuberculosis
67 genes, 80 drugs (DrugBank) and 104 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 72 diseases
Viral protein interaction with cytokine and cytokine receptor
18 genes, 31 drugs (DrugBank) and 68 diseases
Yersinia infection
25 genes, 43 drugs (DrugBank) and 78 diseases
